Wagner, Michael

Copy number variation in obsessive-compulsive disorder and tourette syndrome: A cross-disorder study

McGrath, L. M., Yu, D., Marshall, C., Davis, L. K., Thiruvahindrapuram, B., Li, B., Cappi, C., Gerber, G., Wolf, A., Schroeder, F. A., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry

Obsessive-Compulsive Spectrum DisordersGenomic variations and chromosomal abnormalities

Cited by 141

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Jansen, I. E., van der Lee, S. J., Gomez-Fonseca, D., de Rojas, I., Dalmasso, M. C., Grenier-Boley, B., Zettergren, A., Mishra, A., Ali, M., Andrade, V., et al. (2022) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 132

Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression

Schulze-Rauschenbach, S. C., Harms, U., Schlaepfer, T. E., Maier, W., Falkai, P., & Wagner, M. (2005) · British Journal of Psychiatry

Electroconvulsive Therapy StudiesTranscranial Magnetic Stimulation Studies

Cited by 122

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

DESGESCO (Dementia Genetics Spanish Consortium), E. (. D. E. D. B., van der Lee, S. J., biobank), E. (. D. E. D., IFGC (International FTD-Genomics Consortium), I. (. I. P. D. G. C., IPDGC (The International Parkinson Disease Genomics Consortium), Dementia), R.-F. (. A. M. F. I. F.-T., (NBB), N. B. B., The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Conway, O. J., Jansen, I., et al. (2019) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 120

Anticholinergic drug use and risk for dementia: target for dementia prevention

Jessen, F., Kaduszkiewicz, H., Daerr, M., Bickel, H., Pentzek, M., Riedel-Heller, S., Wagner, M., Weyerer, S., Wiese, B., van den Bussche, H., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 119

Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

Wolfsgruber, S., Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., et al. (2017) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 114

Sleep deprivation disrupts prepulse inhibition and induces psychosis-like symptoms in healthy humans

Petrovsky, N., Ettinger, U., Hill, A., Frenzel, L., Meyhofer, I., Wagner, M., Backhaus, J., & Kumari, V. (2014) · Journal of Neuroscience

Schizophrenia research and treatmentSleep and Work-Related Fatigue

Cited by 102

Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

Lacour, A., Espinosa, A., Louwersheimer, E., Heilmann, S., Hernández, I., Wolfsgruber, S., Fernández, V, Wagner, H., Rosende-Roca, M., Mauleón, A., et al. (2017) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 101

The precuneus and the insula in self-attributional processes

Cabanis, M., Pyka, M., Mehl, S., Müller, B. W., Loos-Jankowiak, S., Winterer, G., Wölwer, W., Musso, F., Klingberg, S., Rapp, A. M., et al. (2013) · Cognitive, Affective, & Behavioral Neuroscience

Neural and Behavioral Psychology StudiesFree Will and Agency

Cited by 97

Differential Risk of Incident Alzheimer’s Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline

Wolfsgruber, S., for the AgeCoDe Study Group, Kleineidam, L., Wagner, M., Mösch, E., Bickel, H., Lϋhmann, D., Ernst, A., Wiese, B., Steinmann, S., et al. (2016) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

Cited by 94

Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer’s disease dementia

Luck, T., Riedel-Heller, S. G., Luppa, M., Wiese, B., Köhler, M., Jessen, F., Bickel, H., Weyerer, S., Pentzek, M., König, H.-H., et al. (2014) · Psychological Medicine

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 93

Cortical Thinning in Individuals with Subjective Memory Impairment

Meiberth, D., Scheef, L., Wolfsgruber, S., Boecker, H., Block, W., Träber, F., Erk, S., Heneka, M. T., Jacobi, H., Spottke, A., et al. (2015) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 84

Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment

Zobel, A. W., Schulze-Rauschenbach, S., von Widdern, O. C., Metten, M., Freymann, N., Grasmäder, K., Pfeiffer, U., Schnell, S., Wagner, M., & Maier, W. (2004) · Journal of Psychiatric Research

Stress Responses and CortisolTreatment of Major Depression

Cited by 75

Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)

Scheef, L., Grothe, M. J., Koppara, A., Daamen, M., Boecker, H., Biersack, H., Schild, H. H., Wagner, M., Teipel, S., & Jessen, F. (2019) · NeuroImage: Clinical

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 63

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 62

Antisaccade performance in patients with obsessive–compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype

Lennertz, L., Rampacher, F., Vogeley, A., Schulze-Rauschenbach, S., Pukrop, R., Ruhrmann, S., Klosterkötter, J., Maier, W., Falkai, P., & Wagner, M. (2012) · European Archives of Psychiatry and Clinical Neuroscience

Obsessive-Compulsive Spectrum DisordersNeural and Behavioral Psychology Studies

Cited by 62

Neural correlates of working memory deficits and associations to response inhibition in obsessive compulsive disorder

Heinzel, S., Kaufmann, C., Grützmann, R., Hummel, R., Klawohn, J., Riesel, A., Bey, K., Lennertz, L., Wagner, M., & Kathmann, N. (2018) · NeuroImage: Clinical

Obsessive-Compulsive Spectrum DisordersNeural and Behavioral Psychology Studies

Cited by 55

Characterization of SLITRK1 variation in obsessive-compulsive disorder

Ozomaro, U., Cai, G., Kajiwara, Y., Yoon, S., Makarov, V., Delorme, R., Betancur, C., Ruhrmann, S., Falkai, P., Grabe, H. J., et al. (2013) · PLoS ONE

Obsessive-Compulsive Spectrum DisordersGenetics and Neurodevelopmental Disorders

Cited by 52

Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging

The DELCODE Study Group, Brueggen, K., Dyrba, M., Cardenas-Blanco, A., Schneider, A., Fliessbach, K., Buerger, K., Janowitz, D., Peters, O., Menne, F., et al. (2019) · Journal of Neurology

Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications

Cited by 51

Alexithymia in obsessive–compulsive disorder — Results from a family study

Grabe, H. J., Ruhrmann, S., Ettelt, S., Müller, A., Buhtz, F., Hochrein, A., Schulze-Rauschenbach, S., Meyer, K., Kraft, S., Reck, C., et al. (2006) · Psychotherapy and Psychosomatics

Psychosomatic Disorders and Their TreatmentsObsessive-Compulsive Spectrum Disorders

Cited by 49

Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

Martino Adami, P. V., Orellana, A., García, P., Kleineidam, L., Alarcón-Martín, E., Montrreal, L., Aguilera, N., Espinosa, A., Abdelnour, C., Rosende-Roca, M., et al. (2022) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

Omega-3 blood levels and stroke risk: a pooled and harmonized analysis of 183 291 participants from 29 prospective studies

O’Keefe, J. H., Tintle, N. L., Harris, W. S., O’Keefe, E. L., Sala-Vila, A., Attia, J., Garg, G. M., Hure, A., Bork, C. S., Schmidt, E. B., et al. (2024) · Stroke

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 46

Potentially inappropriate medication: Association between the use of antidepressant drugs and the subsequent risk for dementia.

Heser, K., Luck, T., Röhr, S., Wiese, B., Kaduszkiewicz, H., Oey, A., Bickel, H., Mösch, E., Weyerer, S., Werle, J., et al. (2018) · Journal of Affective Disorders

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 38

Prediction of dementia of Alzheimer type by different types of subjective cognitive decline

Jessen, F., Kleineidam, L., Wolfsgruber, S., Bickel, H., Brettschneider, C., Fuchs, A., Kaduszkiewicz, H., König, H., Mallon, T., Mamone, S., et al. (2020) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

Cited by 37